Virtual Care for Acute Kidney Injury
(UPTAKE-VC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach for caring for individuals who have experienced acute kidney injury (AKI) and are at high risk of hospital readmission. Participants will either receive virtual care at home, which includes digital health tools and support from healthcare professionals, or continue with their usual care after discharge. The trial aims to determine if virtual care (also known as telemedicine or remote monitoring) can reduce hospital time, prevent readmissions, and improve long-term health outcomes. Individuals hospitalized for more than 48 hours with AKI and at high risk of readmission might be suitable for this trial. As an unphased trial, this study provides a unique opportunity to explore innovative care methods that could enhance recovery and reduce hospital visits.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this method is safe for patients with acute kidney injury?
Research shows that virtual care, including the digital health tools used in this trial, is generally easy for people to use. Studies have found that remote patient monitoring can enhance care for those recovering from acute kidney injury (AKI), aiming to smooth the transition from hospital to home.
Although specific numbers on side effects are unavailable, digital health tools have supported recovery and shortened hospital stays. No strong evidence indicates major safety concerns, and these tools have effectively managed AKI. These methods aim to make recovery safer and more efficient without adding extra risks.12345Why are researchers excited about this trial?
Researchers are excited about virtual care for acute kidney injury because it offers a more personalized and convenient approach to managing health after a hospital stay. Unlike the usual care where patients go home without additional support, virtual care uses technology to create a seamless transition from hospital to home by connecting patients with healthcare providers remotely. This method not only aims to reduce readmission rates by providing continuous monitoring and support but also empowers patients to manage their health more effectively from the comfort of their home.
What evidence suggests that this virtual care method is effective for acute kidney injury?
This trial will compare Virtual Care with Usual Care for patients with acute kidney injury (AKI). Research has shown that virtual care, provided to participants in the Virtual Care arm, can enhance recovery for AKI patients. Studies have found that remote monitoring can improve the quality and speed of care for those who have experienced AKI. Programs enabling patients to receive hospital-level care at home through remote monitoring can shorten hospital stays and reduce readmission rates. Digital health tools can also predict and manage risks related to AKI, potentially preventing kidney failure and other complications. Video-based telemedicine is increasingly common in kidney care, facilitating easier access for patients. This suggests that digital health solutions might effectively improve long-term outcomes for AKI patients.12346
Who Is on the Research Team?
Matthew James, MD
Principal Investigator
University of Calgary
Are You a Good Fit for This Trial?
This trial is for hospitalized adults with Acute Kidney Injury (AKI) who are at high risk of being readmitted to the hospital or dying. The study aims to help these individuals by using virtual care strategies.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Vanguard Phase
Initial implementation to establish feasibility and acceptability of the intervention
Treatment
Participants receive virtual care through Virtual Home Hospital programs, including digital remote patient monitoring and regular virtual assessments
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of kidney function and complications of AKI
What Are the Treatments Tested in This Trial?
Interventions
- Virtual Care
Virtual Care is already approved in Canada for the following indications:
- Acute Kidney Injury (AKI)
- Reducing hospital readmission rates
- Improving long-term outcomes
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Calgary
Lead Sponsor
Alberta Health services
Collaborator